Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Nicole Ruggiero
CEO
nicole.ruggiero@epivaxtx.com

Message the company or request a 1:1 meeting here

EpiVax Therapeutics (‘EVT’), an emerging biotechnology company, employs a world-leading technology developed over two decades, to design vaccines that generate a strong T cell response. We design highly specific, personalized tumor targeting immune therapies that can be delivered to the patient in record time.